RecruitingAnxietyMood Disorders
Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
Eligible age
5–14 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.
Sponsor: Stanford University
You may qualify if…
- ✓ Diagnosed with a mood and/or anxiety disorder
- ✓ Have proficiency to participate in psychotherapy in English
- ✓ Scheduled to begin therapy at one of the study sites
- ✓ RCADS score \> 65
You may not qualify if…
- ✕ \- Comorbid diagnosis of intellectual disability, autism spectrum disorder, psychotic disorders, high-risk suicidal behaviors requiring immediate hospitalization, substance use disorders, or other physical or mental condition that would prohibit them from engaging in telehealth settings.
Where it's recruiting
California
Monterey · Stanford
Source: ClinicalTrials.gov · NCT07155707 · last updated 2026-06-29